GlaxoSmithKline Intellectual Property Development Limited
发明人:
申请号:
EP18829472.2
公开号:
EP3720843A1
申请日:
2018.11.28
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
Provided are IDO1 inhibitor compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.